About ACTEMRA
ACTEMRA is a Healthcare company based in United States founded in 2003. Biotechnology firm creating treatments for diseases including arthritis and COVID-19. It operates on a B2B model. Its website actemra.com draws about 681 thousand monthly visits. ACTEMRA offers products and services including ACTEMRA. Its focus areas include Biotechnology, Biopharmaceuticals, Infectious Diseases and Immunology. Its legal entity is Genentech, Inc. Its competitors include Arialys and Medsite; 2 of its 2 listed competitors have raised funding.
Company details
Genentech is a biotechnology company that researches, develops, and manufactures biopharmaceutical products for serious medical conditions such as rheumatoid arthritis, giant cell arteritis, and COVID-19. They operate primarily in the United States, focusing on immunology and oncology through partnerships with healthcare professionals. Their activities involve clinical trials and patient support, serving global markets with innovative therapies.
Products & Services of ACTEMRA
ACTEMRA offers a comprehensive portfolio of products and services, including ACTEMRA.
Medication for treating rheumatoid arthritis and COVID-19.
Apps and channels of ACTEMRA
its YouTube channel Roche has 20.8K subscribers and 30 videos.
Videos from ACTEMRA
The most watched videos on ACTEMRA's YouTube channel, Roche (20.8K subscribers). Click a video to play it here.
More on Roche.
Competitors of ACTEMRA
ACTEMRA has 2 listed competitors in our database, 2 of them funded. They include Arialys and Medsite.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| arialysrx.com | 2021 | La Jolla, United States | $72.8M | Precision medicines for autoimmune neuropsychiatric diseases are developed. | ||
| medsite.com | 1997 | New York, United States | $55.7M | Interactive medical education, promotion, and physician recruitment solutions are offered. |
Detailed competitors of ACTEMRA
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ACTEMRA
The website of ACTEMRA (actemra.com) receives about 680.7K visits a month and ranks #1,945,833 among all websites worldwide, #2,761 in Pharmacy.
- Monthly visits680.7K
▼ 6.7% vs previous month
- Unique visitors6.2K
per month
- Global rank#1,945,833
among all websites
- Category rank#2,761
Health · Pharmacy
- Bounce rate58%
- Pages per visit1.5
- Average visit28 sec
- DevicesDesktop 21% · Mobile 79%
Websites whose visitors overlap most with ACTEMRA. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for ACTEMRA
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
3 companies that operate in the same segment as ACTEMRA (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Actemra
Complete news archive for ACTEMRA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ACTEMRA
ACTEMRA was founded in 2003.
ACTEMRA is headquartered in United States.
Genentech is a biotechnology company that researches, develops, and manufactures biopharmaceutical products for serious medical conditions such as rheumatoid arthritis, giant cell arteritis, and COVID-19. They operate primarily in the United States, focusing on immunology and oncology through partnerships with healthcare professionals. Their activities involve clinical trials and patient support, serving global markets with innovative therapies.
ACTEMRA offers ACTEMRA.
ACTEMRA operates through Genentech, Inc..
The website of ACTEMRA receives about 681 thousand visits a month and ranks #1,945,833 among all websites worldwide.